Intersubject variation in absorption of digoxin in normal volunteers.
The absorption of oral digoxin preparations was evaluated following single-dose administration of 0.5 mg of digoxin to 16 normal volunteers in a randomized crossover design. Absorption was estimated using the cumulative excretion of digoxin in urine for 7 days and the area under the 24-hr serum digoxin concentration curve (AUC). Significant intersubject variability was observed with both parameters, but this variability was greater for the AUC. After intravenous administration, the 7-day digoxin excretion was 68% of the dose. The elixir and a rapid dissolution tablet were significantly better absorbed (84.5 and 77.8%, respectively) than was a slow dissolution tablet (66.7%), as reflected by the fraction of the amount excreted in the urine following intravenous administration of the same dose. There was a highly significant correlation between the cumulative digoxin excretion in urine during the first 2 days compared to 7 days (r = +0.972,p less than 0.001). Bioavailability of oral digoxin preparations can be reliably determined by comparison of the cumulative 2-day excretion of digoxin following a single dose.
D000284:Administration, Oral; D000328:Adult; D000704:Analysis of Variance; D001702:Biopharmaceutics; D004077:Digoxin / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D013607:Tablets; D013997:Time Factors
D013607:Tablets; D004077:Digoxin